《Table 6 Biological pathways associated with PD pathogenesis and molecular mechanisms》

《Table 6 Biological pathways associated with PD pathogenesis and molecular mechanisms》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Translational Informatics for Parkinson's Disease:from Big Biomedical Data to Small Actionable Alterations》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
Note:DBL,3,4-dihydroxybenzalacetone;MPTP,1-methyl-4-phenyl-1,2,4,6,-tetrahydropyridine;6-OHDA,6-hydroxydopamine;MPP,1-methyl-4-phenylpyridinium.

PD patients can be treated with levodopa or other dopamine replacement drugs,and surgical approaches,including pallidotomy and thalamotomy,could be alternatives.The responses and side effects of these therapies can be personalized to each patient[77,78].Big data could also provide a direct search and mapping method for the clinical decision of which treatment to use,as shown in Figure 4.However,identifying suitable subpopulations for efficient treatments is always a challenge for clinical application.